Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cabergoline-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cabergoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cabergoline adverse reaction |
Causative agent (attribute) |
True |
Cabergoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to cabergoline |
Causative agent (attribute) |
False |
Cabergoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cabergoline [parkinsons] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cabergoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cabergoline 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cabergoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cabergoline 2mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cabergoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cabergoline 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cabergoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cabergoline 500micrograms tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cabergoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cabergoline 0.5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cabergoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to cabergoline |
Causative agent (attribute) |
True |
Cabergoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cabergoline 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cabergoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cabergoline 1 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Cabergoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cabergoline 2mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cabergoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cabergoline 2mg tablet (substance) |
Has basis of strength substance (attribute) |
True |
Cabergoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cabergoline 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cabergoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cabergoline 4 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Cabergoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cabergoline 500micrograms tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cabergoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cabergoline 500micrograms tablet (substance) |
Has basis of strength substance (attribute) |
True |
Cabergoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cabergoline 500micrograms tablet (substance) |
Has precise active ingredient |
True |
Cabergoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cabergoline 1 mg oral tablet |
Has precise active ingredient |
True |
Cabergoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cabergoline 2mg tablet (substance) |
Has precise active ingredient |
True |
Cabergoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Cabergoline 4 mg oral tablet |
Has precise active ingredient |
True |
Cabergoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing cabergoline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cabergoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only cabergoline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cabergoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only cabergoline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cabergoline |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |